# FDA 483 - Leila Chaychi, M.D. - October 22, 2021

Source: https://www.globalkeysolutions.net/records/483/leila-chaychi-md/5ef7f15c-cff3-47a6-9d41-4ca32fa5eef3

> FDA 483 for Leila Chaychi, M.D. on October 22, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Leila Chaychi, M.D.
- Inspection Date: 2021-10-22
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: An FDA inspection of Leila Chaychi, M.D., a clinical investigator in San Carlos, CA, revealed significant deficiencies in the conduct of clinical investigations. Observations included failures to adhere to investigational plans, enroll eligible subjects, and properly document informed consent. These issues indicate a lack of control over study conduct and subject protection.

## Related Officers

- [Linh Tu](https://www.globalkeysolutions.net/people/linh-tu/142c94dc-9538-4c52-9a5f-be27fc7c4f4b)
- [Investigator ](https://www.globalkeysolutions.net/people/dustin-tran/52b41643-a5f9-4b2e-8da4-24beca42b1cd)

Company: https://www.globalkeysolutions.net/companies/leila-chaychi-md/cf3331d6-715c-47c9-bf49-edc5b6bf3000

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b